Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FL9SL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,467
Award facts
- Contract value 100% obligated
- $17,467.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,467.11 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2mL pen format. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's track record demonstrates consistent competitively-awarded delivery orders with firm fixed pricing ranging from under $100 to over $45,000, reflecting its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains. This award reflects AmerisourceBergen's role as a primary supplier within the DLA's pharmaceutical supply chain infrastructure supporting military personnel and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FL9SL?
SPE2DR26FL9SL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FL9SL worth?
The government has obligated $17,467 on SPE2DR26FL9SL.
Is contract SPE2DR26FL9SL an order under another contract?
Yes. SPE2DR26FL9SL is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL9SL competed?
The extent of competition for SPE2DR26FL9SL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award